Results 81 to 90 of about 132,140 (136)

Using naloxone saturation measures and opioid overdose burden to optimize geographic distribution of naloxone in Rhode Island. [PDF]

J Subst Use Addict Treat
Shin J, Hallowell BD, Marshall BDL, Krieger MS, St John K.   +4 more
europepmc   +1 more source

Strategies to increase medications for opioid use disorder in hospital settings in the USA: protocol for a scoping review. [PDF]

BMJ Open
Hoemann B, Lane A, Laine RO, Shy C, Moller A, Marks L, Hartz SM, Hardi A, Ramsey A, Li J.   +9 more
europepmc   +1 more source

Multilingual analysis of public discourse on opioid and non-opioid analgesics through social media: a cross-sectional infodemiological study. [PDF]

BMC Med Res Methodol
Valades T, Ruiz-Iniesta A, Domingo-Espiñeira J, Chart-Pascual JP, Fraile-Martinez O, García-Montero C, Alvarez-Mon M, Morales I, Mora F, Quintero J, Ortega MA, Perez-Araluce R, Alvarez-Mon MA.   +12 more
europepmc   +1 more source

Iatrogenic physiologic opioid dependence masquerading as recurrent acute pancreatitis flares: case series. [PDF]

Addict Sci Clin Pract
Dayan-Rosenman D, Diletti-Swenson S, Ghayalod N, Sokol R.   +3 more
europepmc   +1 more source

National trends in naloxone codispensing with outpatient opioid prescriptions, 2013-2023. [PDF]

Reg Anesth Pain Med
Beck EJ, Chua KP, Gunaseelan V, Bicket M, Brummett CM, Bohnert A, Waljee JF.   +6 more
europepmc   +1 more source

Participant perspectives on a safe supply program in Vancouver, Canada: impacts, satisfaction and improvement priorities. [PDF]

Harm Reduct J
Mawani Z, Kennedy MC, Holliday E, Sutherland C, Kerr T.   +4 more
europepmc   +1 more source

The Buprenorphine Paradox: How Buprenorphine Triggers and Resolves Opioid Withdrawal. [PDF]

Addict Biol
Haghdoost M, LaBranche J, Roberts M, Li VW, Kim JJ, Wong JSH, Azar P.   +6 more
europepmc   +1 more source

Factors associated with medications for opioid use disorder (MOUD) treatment success during the pregnancy and postpartum periods: A scoping review. [PDF]

Drug Alcohol Depend
Mburu M, Masese R, Knippler ET, Watt MH, Muhirwa A, Ledbetter L, Graton M, Knettel BA.   +7 more
europepmc   +1 more source

Narcotics through time: exploring historical origins, synthetic advances, and clinical progress. [PDF]

Future Med Chem
Kalita RC, Sharma S, Samanta S, Patle D.
europepmc   +1 more source

Buccal and sublingual lyophilised naloxone for opioid overdose reversal: A Phase 1 open-label, random-sequence crossover pharmacokinetic study protocol in healthy volunteers (NalBuc). [PDF]

PLoS One
Gonzalez Utrilla M, Baker A, Chesney E, Lee K, Emsley R, Strang J.   +5 more
europepmc   +1 more source